Global Momelotinib tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Momelotinib tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100 mg tablets
- 1.3.3 200 mg tablets
- 1.4 Market Analysis by Sales Channel
- 1.4.1 Overview: Global Momelotinib tablets Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Retail
- 1.4.4 Online
- 1.5 Market Analysis by Dosage form
- 1.5.1 Overview: Global Momelotinib tablets Consumption Value by Dosage form: 2021 Versus 2025 Versus 2032
- 1.5.2 Tablet
- 1.5.3 Film-coated tablet
- 1.6 Market Analysis by Production Technology
- 1.6.1 Overview: Global Momelotinib tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
- 1.6.2 Generic
- 1.6.3 Innovator
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Momelotinib tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Allergic Rhinitis
- 1.7.3 Chronic Spontaneous Urticaria (CSU)
- 1.7.4 Bronchial Asthma
- 1.7.5 Others
- 1.8 Global Momelotinib tablets Market Size & Forecast
- 1.8.1 Global Momelotinib tablets Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Momelotinib tablets Sales Quantity (2021-2032)
- 1.8.3 Global Momelotinib tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 GlaxoSmithKline plc
- 2.1.1 GlaxoSmithKline plc Details
- 2.1.2 GlaxoSmithKline plc Major Business
- 2.1.3 GlaxoSmithKline plc Momelotinib tablets Product and Services
- 2.1.4 GlaxoSmithKline plc Momelotinib tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 GlaxoSmithKline plc Recent Developments/Updates
3 Competitive Environment: Momelotinib tablets by Manufacturer
- 3.1 Global Momelotinib tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Momelotinib tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Momelotinib tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Momelotinib tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Momelotinib tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Momelotinib tablets Manufacturer Market Share in 2025
- 3.5 Momelotinib tablets Market: Overall Company Footprint Analysis
- 3.5.1 Momelotinib tablets Market: Region Footprint
- 3.5.2 Momelotinib tablets Market: Company Product Type Footprint
- 3.5.3 Momelotinib tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Momelotinib tablets Market Size by Region
- 4.1.1 Global Momelotinib tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Momelotinib tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Momelotinib tablets Average Price by Region (2021-2032)
- 4.2 North America Momelotinib tablets Consumption Value (2021-2032)
- 4.3 Europe Momelotinib tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Momelotinib tablets Consumption Value (2021-2032)
- 4.5 South America Momelotinib tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Momelotinib tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Momelotinib tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Momelotinib tablets Consumption Value by Type (2021-2032)
- 5.3 Global Momelotinib tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Momelotinib tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Momelotinib tablets Consumption Value by Application (2021-2032)
- 6.3 Global Momelotinib tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Momelotinib tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Momelotinib tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Momelotinib tablets Market Size by Country
- 7.3.1 North America Momelotinib tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Momelotinib tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Momelotinib tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Momelotinib tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Momelotinib tablets Market Size by Country
- 8.3.1 Europe Momelotinib tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Momelotinib tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Momelotinib tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Momelotinib tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Momelotinib tablets Market Size by Region
- 9.3.1 Asia-Pacific Momelotinib tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Momelotinib tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Momelotinib tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Momelotinib tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Momelotinib tablets Market Size by Country
- 10.3.1 South America Momelotinib tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Momelotinib tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Momelotinib tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Momelotinib tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Momelotinib tablets Market Size by Country
- 11.3.1 Middle East & Africa Momelotinib tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Momelotinib tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Momelotinib tablets Market Drivers
- 12.2 Momelotinib tablets Market Restraints
- 12.3 Momelotinib tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Momelotinib tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Momelotinib tablets
- 13.3 Momelotinib tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Momelotinib tablets Typical Distributors
- 14.3 Momelotinib tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Momelotinib tablets market size was valued at US$ 25.72 million in 2025 and is forecast to a readjusted size of US$ 763 million by 2032 with a CAGR of 44.9% during review period.
Momelotinib tablets are an orally administered small-molecule Janus kinase (JAK) inhibitor primarily used for the treatment of myelofibrosis and other myeloproliferative neoplasm-related disorders. The drug selectively inhibits the JAK1 and JAK2 signaling pathways, thereby modulating abnormal cytokine signaling, reducing inflammatory responses, improving anemia-related symptoms, and suppressing abnormal hematopoiesis. As a next-generation JAK inhibitor, momelotinib demonstrates certain advantages in improving anemia-related parameters and is suitable for patients who have previously received JAK inhibitor therapy but experienced insufficient efficacy or concomitant anemia. The drug has entered clinical use and is being gradually adopted in the treatment of myelofibrosis.In 2025, global production of mobocertinib reached approximately 1.5 million tablets.
Momelotinib tablets, as a next-generation oral JAK inhibitor, are primarily used in the treatment of myelofibrosis and are positioned within the rapidly growing market for drugs targeting myeloproliferative neoplasms. In recent years, driven by increasing diagnosis rates of rare hematologic malignancies and rising demand for targeted therapies, the global JAK inhibitor market has continued to expand, with marketed products such as ruxolitinib accounting for a significant share of the market. Momelotinib tablets offer a potential differentiated advantage in improving anemia-related outcomes, making them a promising option for patients who have had insufficient response to prior JAK inhibitor therapies or present with concomitant anemia. However, the market is already dominated by well-established drugs, resulting in a highly concentrated competitive landscape. New entrants must achieve breakthroughs through clinical efficacy, long-term safety data, and pricing strategies. Therefore, future market growth will largely depend on indication expansion, clinical data validation, and commercialization progress.
This report is a detailed and comprehensive analysis for global Momelotinib tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Momelotinib tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Momelotinib tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Momelotinib tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Momelotinib tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Momelotinib tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Momelotinib tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Momelotinib tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg tablets
200 mg tablets
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Dosage form
Tablet
Film-coated tablet
Market segment by Production Technology
Generic
Innovator
Market segment by Application
Allergic Rhinitis
Chronic Spontaneous Urticaria (CSU)
Bronchial Asthma
Others
Major players covered
GlaxoSmithKline plc
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Momelotinib tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Momelotinib tablets, with price, sales quantity, revenue, and global market share of Momelotinib tablets from 2021 to 2026.
Chapter 3, the Momelotinib tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Momelotinib tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Momelotinib tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Momelotinib tablets.
Chapter 14 and 15, to describe Momelotinib tablets sales channel, distributors, customers, research findings and conclusion.